chr19-41969470-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 3P and 13B. PM1PP2BP4_StrongBP6BS1BS2
The NM_152296.5(ATP1A3):c.2653G>A(p.Val885Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,614,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_152296.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1A3 | NM_152296.5 | c.2653G>A | p.Val885Ile | missense_variant | 19/23 | ENST00000648268.1 | NP_689509.1 | |
ATP1A3 | NM_001256214.2 | c.2692G>A | p.Val898Ile | missense_variant | 19/23 | NP_001243143.1 | ||
ATP1A3 | NM_001256213.2 | c.2686G>A | p.Val896Ile | missense_variant | 19/23 | NP_001243142.1 | ||
ATP1A3 | XM_047438862.1 | c.2563G>A | p.Val855Ile | missense_variant | 19/23 | XP_047294818.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1A3 | ENST00000648268.1 | c.2653G>A | p.Val885Ile | missense_variant | 19/23 | NM_152296.5 | ENSP00000498113 |
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251486Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135920
GnomAD4 exome AF: 0.0000951 AC: 139AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.0000866 AC XY: 63AN XY: 727244
GnomAD4 genome AF: 0.000512 AC: 78AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | ATP1A3: BS1, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 05, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 20, 2019 | - - |
Dystonia 12 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
ATP1A3-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 30, 2023 | The ATP1A3 c.2692G>A variant is predicted to result in the amino acid substitution p.Val898Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.12% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-42473622-C-T), which may be too common to be causative of disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Alternating hemiplegia of childhood 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Developmental and epileptic encephalopathy 99 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at